scispace - formally typeset
K

Keith A. Cengel

Researcher at University of Pennsylvania

Publications -  210
Citations -  12705

Keith A. Cengel is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 34, co-authored 178 publications receiving 10610 citations. Previous affiliations of Keith A. Cengel include University of Illinois at Urbana–Champaign & Hospital of the University of Pennsylvania.

Papers
More filters
Journal ArticleDOI

PDT dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT)

Yi Hong Ong, +7 more
- 29 Dec 2017 - 
TL;DR: A four-channel PDT dose Dosimetry system to simultaneously acquire light dosimetry and photosensitizer fluorescence data and an empirical optical property correction function using Monte Carlo simulations of fluorescence for a range of physiologically relevant tissue optical properties is determined.
Journal ArticleDOI

Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesothelioma.

Kevin L. Du, +5 more
- 01 Sep 2010 - 
TL;DR: The experience with a multimodality approach for the treatment of mesothelioma, incorporating extrapleural pneumonectomy, intraoperative photodynamic therapy and postoperative hemithoracic IMRT, appears safe and effective.
Journal ArticleDOI

Using electron beam radiation to simulate the dose distribution for whole body solar particle event proton exposure

Keith A. Cengel, +4 more
- 20 Aug 2010 - 
TL;DR: The novel concept of using megavoltage electron beam radiation to more accurately reproduce both the total dose and the dose distribution of SPE protons and make meaningful RBE comparisons between protonsand conventional radiation is described.
Journal ArticleDOI

Immunotherapy and radiation therapy for malignant pleural mesothelioma

Evan W. Alley, +3 more
- 01 Apr 2007 - 
TL;DR: The rationale for combining immunotherapy with radiation therapy, and early literature on this treatment combination are described, which may allow for complimentary immunologic effects that can enhance antitumor response.
Journal ArticleDOI

Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis

Abhishek Chandra, +13 more
- 01 Jan 2018 - 
TL;DR: A novel role of proteasome inhibitors is demonstrated in treating radiation‐induced osteoporosis by reversing the loss of trabecular bone structure and strength in mice at 4 wk after focal radiation and suppressing the number and activity of osteoclasts, regardless of irradiation.